Giardia duodenalis (syn. G. lamblia/G. intestinalis) is a protozoan flagellate (Diplomonadida) [1], responsible for human giardiasis.

Distributed on a global scale as a cause of gastroenteritis in both developed and resource limited nations, it has been estimated that Giardia parasites infect more than 200 million individuals every year [2].

Giardiasis is a nationally reportable disease and is one of the most common causes of waterborne disease in the United States (US). Regularly associated with waterborne parasite outbreaks in summer months, infection is underreported at 20,000 cases in the US each year, with real cases estimated at 1-2 million.[3,4]

 Giardia infection rarely causes death in the US, however, 4,600 people are hospitalized with giardiasis each year.[4] Giardia parasites are commonly found in bodies of water, particularly untreated or poorly treated water sources such as rivers, lakes, ponds, and streams but also in public water supplies and swimming pools.[5]

Giardia symptoms, prevention & treatment

Patients infected with the Giardia parasite can experience a wide range of symptoms.

Learn more here

Giardia laboratory diagnosis

Learn more about the challenges of traditional diagnostic techniques for detecting Giardia infection, and the benefits of molecular testing

Genetic Signatures' molecular solution for GI parasite testing

A comprehensive FDA 510(k) cleared molecular solution for detecting gastrointestinal parasites

Syndromic testing for 8 gastrointestinal parasites in a single test

Up to 60 patients screened in a single, automated workflow...with same day reporting!

Genetic Signatures Syndromic workflow for detecting gastrointestinal parasites

Find out more about our unique 3base™ solution for detecting gastrointestinal parasites

3base™ advantage for parasite testing

The benefits of employing 3base™ technology for multiplex real-time PCR detection of gastrointestinal parasites

Webinars, blogs, podcasts

Leading parasitologists speak to the challenges of detecting GI parasites and the benefits of molecular testing

White papers, publications

Clinical evidence supporting the benefits of molecular testing for gastrointestinal parasites

Case studies & testimonials

Learn what industry leaders think of Genetic Signatures' novel solution for GI parasite detection

Clinically important parasites

An overview of the leading gastrointestinal parasites: Symptoms, diagnosis and treatment

References

  1. www.cdc.gov/dpdx/giardiasis/index.html#:~:text=Acute%20giardiasis%20develops%20after%20an,malabsorption%20and%20debilitation%20may%20occur
  2. Maikai BV, Umoh JU, Lawal IA, Kudi AC, Ejembi CL, Xiao L. Molecular characterizations of Cryptosporidium, Giardia, and Enterocytozoon in humans in Kaduna State, Nigeria. Exp Parasitol. 2012 Aug;131(4):452-6. doi: 10.1016/j.exppara.2012.05.011. Epub 2012 Jun 1. PMID: 22664352.
  3. Cama VA & Mathison BA (2015), Infections by Intestinal Coccidia and Giardia duodenalis. Clin Lab Med, 35(2): 423–444
  4. Giardia Factsheet
  5. https://www.mayoclinic.org/diseases-conditions/giardia-infection/symptoms-causes/syc-20372786